Advertisement
YOU ARE HERE: LAT HomeCollectionsBreast Cancer
IN THE NEWS

Breast Cancer

SCIENCE
February 18, 2014 | By Melissa Healy, This post has been corrected, as indicated below.
A team of researchers from the City of Hope in Duarte has developed a speedy way to identify drugs and chemicals that can disrupt the balance of sex hormones in human beings and influence the development and progress of diseases such as breast cancer. In a trial screening of 446 drugs in wide circulation, the new assay singled out the popular antidepressant paroxetine (better known by its commercial name, Paxil) as having a weak estrogenic effect that could promote the development and growth of breast tumors in women.
Advertisement
NEWS
February 2, 2012 | By Shari Roan, Los Angeles Times / For the Booster Shots blog
The long-debunked idea that abortions can contribute to breast cancer is reappearing amid the outpouring of comments this week on Susan G. Komen for the Cure's decision to stop funding Planned Parenthood breast-health programs. Here's one comment on Komen's Facebook page: "Also! Breast cancer is linked to abortions!!! More and more studied are pointing to abortions for a huge risk factor for BC, why should SGK support something that raises the chances of what they wasn't destroyed?
HEALTH
January 26, 2009 | Marc Siegel, Siegel is an internist and an associate professor of medicine at New York University's School of Medicine.
"Nip/Tuck" FX, season premiere: Jan. 6 and 13, 10 p.m. The premise Plastic surgeon Dr. Christian Troy (Julian McMahon) takes his associate Dr. Liz Cruz (Roma Maffia) for a mammogram because he thinks he felt a lump in her breast. The test is negative but, while at the radiologist's office, Troy admits that he himself has felt a lump in his own chest.
NEWS
April 4, 2011 | By Marissa Cevallos, HealthKey
Breast milk may do more than sustain an infant; in the future, it could also be used to help assess breast cancer risk.  At least, that’s what a small study hints. By screening breast milk for cells that can turn into cancer, researchers believe they can develop a way to warn women if they’re at an increased risk of developing breast cancer later in life. Results from the new study were presented Monday at the American Assn. for Cancer Research in Orlando.  Researchers  at the University of Massachusetts Amherst  collected fresh milk samples from about 250 women, one sample from each breast.
NEWS
October 28, 2010 | By Mary Forgione, Los Angeles Times
For many women, the fight against breast cancer is public, with support from friends and family and frequent discussions with healthcare professionals about side effects and treatment. But part of that fight is intensely private -- rarely more so than when it affects their sex life. Certain chemotherapy drugs send women into early menopause within a few months. That, coupled, with hair loss and disfiguring mastectomies, leave some breast cancer survivors struggling to be intimate again, a new study finds.
NEWS
December 10, 2010 | By Shari Roan, Los Angeles Times
The breast cancer drug pertuzumab when added to Herceptin improved the treatment of women with early-stage, HER-2 positive breast cancer, researchers reported Friday at the annual meeting of the San Antonio Breast Cancer Symposium . Pertuzumab is an experimental monoclonal antibody. In the study, 417 women received monoclonal antibody drug therapy before having surgery to remove the tumor. Some women also underwent chemotherapy. Adding pertuzumab to Herceptin -- which is also known by the generic name trastuzumab -- along with the chemotherapy drug docetaxel led to a tumor eradication rate of 46%. That is 50% better than the tumor eradication rate achieved with the standard therapy of docetaxel and Herceptin combined, said the authors of the paper, from the National Cancer Institute in Milan, Italy.
NEWS
September 30, 2010 | Pregnant breast cancer patients more likely to survive
There may be few pregnancy nightmares worse than finding a lump in one's breast, given the dueling fears that if it's cancer, treatment could harm the developing fetus, while delay and pregnancy hormones could fuel a tumor's growth. But a new study finds that pregnant women treated for breast cancer are more likely to survive their ordeal than breast cancer patients of the same age who were not pregnant when their cancer was diagnosed. Five years after their diagnosis, almost 74% of the women diagnosed with breast cancer during pregnancy were still alive.
NEWS
November 28, 2012 | By Jon Bardin
A new genetic test may help determine whether a small tumor in the breast is likely to turn in to full-blown breast cancer, according to a study published Wednesday in the Journal of the National Cancer Institute. The small tumor, called a ductal carcinoma in-situ, or DCIS, resides in the milk ducts and is generally considered pre-cancerous. But according to the study, DCIS lesions left untreated will eventually progress to breast cancer in about 50% of patients. The lesions, which tend to be small and only detectable via mammogram, have become increasingly common as mammography has become more widespread.
NEWS
March 13, 2013 | By Eryn Brown
These days, thanks to advances in treatment and detection, millions of women survive breast cancer.   But surviving the disease doesn't necessarily mean the entire battle is over, a population-based study of breast cancer survivors in Sweden and Denmark, published Wednesday in the New England Journal of Medicine , seems to suggest. Assessing a total of 2,168 women whose breast cancer was treated with radiation therapy between 1958 and 2001, a team of researchers found that women's chances of having a major coronary event - a heart attack, bypass surgery or heart disease death - rose in proportion with the radiation dose they received, even at the lower doses of radiation delivered in newer treatments.
Los Angeles Times Articles
|